- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02480231
Mid-Urethral Sling Tensioning Trial (MUST)
March 30, 2020 updated by: Erin Brennand, University of Calgary
Prospective randomized clinical trial comparing two methods of intra-operative tensioning of retropubic midurethral slings for stress urinary incontinence.
Primary outcome is rate of abnormal bladder function.
Secondary outcomes include validated quality of life scores, physical exam findings, and rates of immediate post operative voiding dysfunction.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
318
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4J8
- Foothills Hospital, University of Calgary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age 18 or older
- Women who have elected for surgical management of symptomatic urinary incontinence
- Ability to read & write in English
- Other prolapse surgery at time of sling placement is allowed
- Must consent to participation in trial
Exclusion Criteria:
- Women with a prior incontinence procedure
- Clinically obvious, but non-symptomatic stress urinary incontinence (latent stress incontinence)
- Declines participation in trial
- Women with existing urinary retention or significant overactive bladder (requiring medication)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Babcock tensioning technique
Group for whom the retropubic mid-urethral sling was tensioned using a Babcock clamp.
|
Other Names:
|
|
Active Comparator: Scissor spacer technique
Group for whom the retropubic mid-urethral sling was tensioned using a surgical scissor as a spacer.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Abnormal Bladder Function
Time Frame: 1 year post operative
|
Abnormal post-operative bladder function a composite outcome assessed at 12 months after surgery.
It is one or more of the following: 1) significantly bothersome stress incontinence or over active bladder symptoms after surgery as measured by questions 1, 2, 3 of the Urogential Distress Inventory (UDI-6) 2) a positive cough stress test in the office, 3) re-treatment for stress urinary incontinence (repeat surgery or pessary use), 4) post-operative urinary retention (presence of self-catheterization at 6 weeks post-operatively or beyond, or therapeutic intervention for retention at any time during the 12 months after, such as pelvic floor physiotherapy, sling lysis, urethrolysis, or sacral nerve stimulation.
|
1 year post operative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of discharge from hospital with on-going need for catheterization
Time Frame: 12 months
|
12 months
|
|
|
Duration of catheterization after surgery
Time Frame: 12 months
|
12 months
|
|
|
Questionnaire scores
Time Frame: 12 months
|
standardized questionnaire scores (UDI-6, Incontinence Impact Questionnaire, International Consultation on Incontinence Modular Questionnaire)
|
12 months
|
|
Pad test
Time Frame: 12 month
|
Standardized 1 hour pad test values
|
12 month
|
|
Uroflow parameters
Time Frame: 12 months
|
Maximum urine flow rate, post void residual
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Erin A Brennand, MD, University of Calgary
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
April 1, 2019
Study Completion (Actual)
March 1, 2020
Study Registration Dates
First Submitted
June 17, 2015
First Submitted That Met QC Criteria
June 19, 2015
First Posted (Estimate)
June 24, 2015
Study Record Updates
Last Update Posted (Actual)
April 1, 2020
Last Update Submitted That Met QC Criteria
March 30, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB15-0455
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Stress Incontinence
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
GT Urological, LLCCompletedMale Stress Urinary IncontinenceAustralia, Czechia, New Zealand
-
Zekai Tahir Burak Women's Health Research and Education...CompletedFemale Urinary Stress IncontinenceTurkey
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States
Clinical Trials on Retropubic Midurethral Sling
-
Oregon Health and Science UniversityCollins Medical TrustUnknownStress Urinary IncontinenceUnited States
-
University of Alabama at BirminghamRecruitingPelvic Organ Prolapse | Stress Incontinence FemaleUnited States
-
University Hospital, GrenobleNot yet recruitingStress Urinary Incontinence
-
David ScheinerUniversity of ZurichTerminated
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedUrinary Incontinence, Stress
-
sarah mohamed hassanCompleted
-
Coloplast A/SCompletedStress Urinary IncontinenceUnited States, Canada
-
The Cleveland ClinicCompleted
-
University of Sao Paulo General HospitalEnrolling by invitationPelvic Organ Prolapse | Urinary Stress IncontinenceBrazil
-
HealthCore-NERICompleted